Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
03/2004
03/25/2004US20040057946 Forming a solution of protein encapsulated, insoluble gas-filled microbubbles conjugated to biological agent; administering solution to animal; so that protein directs microbubble-conjugated agent to sites of bioprocessing
03/24/2004EP1399188A2 Perylenequinones for use as photosensitizers and sonosensitizers
03/24/2004EP1399170A2 Chelates of metals which can be activated by neutrons and their use for the measurement of labeled specimens
03/24/2004CN1484706A Photochemical internalization for virus-mediated molecule delivery into the cyosol
03/23/2004WO2004080458A1 Treatment of proliferative diseases with epothilone derivatives and radiation
03/23/2004US6710066 Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
03/23/2004CA2519037A1 Treatment of proliferative diseases with epothilone derivatives and radiation
03/19/2004CA2440914A1 Process for sterilization of protein containing biological compositions
03/18/2004WO2004021982A2 Chemotherapy method using-rays
03/18/2004WO2003092623A3 Calicheamicin derivative-carrier conjugates
03/18/2004WO2003090744A8 Antibacterial compositions comprising metal phthalocyanine analogues
03/18/2004US20040053935 Anticancer agents
03/18/2004US20040053934 Anticancer agents
03/18/2004US20040053900 Administering to a mammal a combination of cyclooxygenase-2 inhibitor and aromatase inhibitor for the prevention, or inhibition of a neoplasia, a neoplasia-related disorder, or osteoporosis in mammal in need
03/18/2004US20040053873 Electroporation methods for introducing bioactive agents into cells
03/18/2004US20040053217 Using conjugate agents comprise of photoreactive moiety to identify preferential micro and/or macromolecules in heterologous mixtures
03/18/2004US20040052785 Synergistic mixtures; antitumor agents
03/17/2004EP1397429A1 Composite particles, derived conjugates, preparation method thereof and applications of same
03/17/2004EP1030686B1 Lyophilizate of lipid complex of water insoluble porphyrins
03/17/2004CN1481825A Oral compositions for white blood cell activation and proliferation
03/17/2004CN1481824A Oral compositions for hiv-infected subjects
03/17/2004CN1141929C Medicament formulation
03/16/2004US6706254 Cyanine dye bioconjugates useful for diagnostic imaging and therapy
03/16/2004US6706011 Laser assisted drug delivery
03/11/2004WO2004009138A3 Methods for sterilizing milk
03/11/2004WO2003094929A3 Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
03/11/2004US20040049247 Apparatus for skin treatment
03/11/2004US20040048842 Delivering a beam of pulsed or scanned radiation to induce selective photothermolysis of blood vessels disposed within the region, and to activate the photosensitizer that has been administered locally to the region
03/11/2004US20040048795 Stimulating a vagus nerve pathway in the brain; inhibiting apoptosis of a cardiac myocyte
03/11/2004US20040047913 For use in photodynamic therapy
03/11/2004US20040047835 Combinations of drug conjugates with other therapeutic agents, including chemotherapy drugs. The invention also provides methods of using the combinations for the treatment of diseases associated with cell proliferation such as tumors
03/11/2004US20040047804 Enhanced radiation therapy based on the discovery that by using controlled combinations of specific radiodense compositions, (ii) specific modes of administration of these radiodense compositions, and (iii) specific energy bands and
03/11/2004US20040046127 Turbine-boosted ultraviolet-radiation sterilizing fluid processor
03/10/2004EP1395256A2 Prodrugs via acylation with cinnamate
03/09/2004US6703375 Molecular chemotherapy enhancement of radiotherapy
03/04/2004WO2004018686A1 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression
03/04/2004WO2004018471A1 Nucleic acid damage using riboflavin and light
03/04/2004WO2004018456A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
03/04/2004WO2002085459A3 Antiangiogenic combination therapy for the treatment of cancer
03/04/2004US20040044304 Local drug delivery using photosensitizer-mediated and electromagnetic radiation enhanced vascular permeability
03/04/2004CA2495050A1 Two-photon absorption heteroaromatic chromophores and compositions thereof
03/03/2004EP1394249A1 Dietary supplements beneficial for the gastrointestinal system
03/03/2004EP1392666A1 Biologically active methylene blue derivatives
03/03/2004EP1392328A2 Cancer therapy
03/03/2004EP1392324A1 Chemoprotection using amifostine and related compounds
03/03/2004EP1392204A2 Bifunctional energy-reversible acyl-compositions
03/03/2004EP0938341B1 Compositions and methods for altering the biodistribution of biological agents
03/03/2004EP0719150B1 Cellular vaccine and its use for the treatment of solid tumor malignancies
03/02/2004US6699724 Metal nanoshells for biosensing applications
03/02/2004US6699040 Material for differently modifying the optical properties of different cells
02/2004
02/26/2004WO2004016211A2 Pi3k antagonists as radiosensitizers
02/26/2004WO2004016148A2 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
02/26/2004WO2004000369A3 Method of magnetically manipulating a cell with magnetisable particles
02/26/2004WO2003040346A3 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
02/26/2004WO2002098501A3 Method and apparatus for treating tumors using low strength electric fields
02/26/2004WO2002083067A9 Prodrugs via acylation with cinnamate
02/26/2004US20040038937 Method and device for avoiding alteration of a substance having biological activities
02/25/2004EP1390080A1 Azo compounds for type i phototherapy
02/25/2004EP1128812B1 Nano-emulsion of 5-aminolevulinic acid
02/25/2004EP0986401B1 P-selectin translocation to vascular epithelial lumen by ionizing radiation
02/25/2004EP0954336B1 Membrane incorporation of texaphyrins
02/24/2004US6697668 Ocular iontophoretic device and method for using the same
02/19/2004WO2004014386A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies
02/19/2004WO2003035104B1 Compositions and methods for selected tumor treatment
02/19/2004US20040034007 Use of green porphyrins to treat neovasculature in the eye
02/19/2004US20040033964 For treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation
02/19/2004US20040033514 Detection of disease related genes
02/19/2004CA2494270A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies
02/17/2004US6693093 Drug delivery systems for photodynamic therapy
02/17/2004US6692456 Apparatus for microporation of biological membranes using thin film tissue interface devices, and method therefor
02/12/2004WO2004013307A2 Compounds for targeting hepatocytes
02/12/2004WO2004013180A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
02/12/2004WO2004012774A1 Conjugates of porphyrin compounds with chemotherapeutic agents
02/12/2004WO2004012667A2 Photoactivated anti-viral and anti-cancer agent
02/12/2004US20040029975 Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds
02/12/2004US20040029856 Photodynamic therapy for the treatment of hair loss
02/12/2004US20040029826 Compounds for targeting hepatocytes in vivo
02/12/2004US20040028609 Two-dimensionally quantified image method for distinguishing and quantifying over-growing tissue or the like
02/12/2004CA2498231A1 Photoactivated anti-viral and anti-cancer agent
02/12/2004CA2494310A1 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
02/12/2004CA2494214A1 Conjugates of porphyrin compounds with chemotherapeutic agents
02/11/2004EP1387701A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
02/10/2004US6689811 Method of using caffeic acid phenethyl ester and analogs thereof as radiation sensitizers
02/10/2004US6689787 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia
02/10/2004US6689398 Triterpene compositions and methods for use thereof
02/05/2004WO2004011631A2 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus
02/05/2004US20040024015 Enhancing chemotherapy/radition therapy; endothelial growth factors; side effects reduction
02/05/2004US20040023942 Novel, water-soluble porphyrin platinum compounds with high tumor selectivity and their use for the treatment of benign and malignant tumor diseases
02/05/2004US20040023891 Agents for neutron capture therapy
02/05/2004US20040022737 Method for using chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
02/05/2004US20040022734 For therapy of cancer, of fluorescent imaging and optoelectronics
02/05/2004US20040021089 Device and method for photoactivation
02/04/2004EP1386927A1 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
02/04/2004CN1137087C Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
02/03/2004US6686480 Psoralen compounds with aminoalkyl groups on the 5' position and optional alkyl groups on positions 4,4' and 8 that bind to nucleic acid of pathogens, and under photoactivation crosslink the nucleic acid, inactivating the pathogen
02/03/2004US6685986 Metal nanoshells
02/03/2004US6685730 Optically-absorbing nanoparticles for enhanced tissue repair
01/2004
01/29/2004WO2004009139A1 Methods for sterilizing recombinant or transgenic material
01/29/2004WO2004009138A2 Methods for sterilizing milk
01/29/2004WO2004009136A2 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 95